C

Cooper Companies Inc
LSE:0I3I

Watchlist Manager
Cooper Companies Inc
LSE:0I3I
Watchlist
Price: 104.23 USD -0.04% Market Closed
Market Cap: 516.8B USD
Have any thoughts about
Cooper Companies Inc?
Write Note

Intrinsic Value

The intrinsic value of one 0I3I stock under the Base Case scenario is 0.77 USD. Compared to the current market price of 104.23 USD, Cooper Companies Inc is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

0I3I Intrinsic Value
0.77 USD
Overvaluation 99%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Cooper Companies Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for 0I3I cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about COO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Cooper Companies Inc

Provide an overview of the primary business activities
of Cooper Companies Inc.

What unique competitive advantages
does Cooper Companies Inc hold over its rivals?

What risks and challenges
does Cooper Companies Inc face in the near future?

Summarize the latest earnings call
of Cooper Companies Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cooper Companies Inc.

Provide P/S
for Cooper Companies Inc.

Provide P/E
for Cooper Companies Inc.

Provide P/OCF
for Cooper Companies Inc.

Provide P/FCFE
for Cooper Companies Inc.

Provide P/B
for Cooper Companies Inc.

Provide EV/S
for Cooper Companies Inc.

Provide EV/GP
for Cooper Companies Inc.

Provide EV/EBITDA
for Cooper Companies Inc.

Provide EV/EBIT
for Cooper Companies Inc.

Provide EV/OCF
for Cooper Companies Inc.

Provide EV/FCFF
for Cooper Companies Inc.

Provide EV/IC
for Cooper Companies Inc.

Show me price targets
for Cooper Companies Inc made by professional analysts.

What are the Revenue projections
for Cooper Companies Inc?

How accurate were the past Revenue estimates
for Cooper Companies Inc?

What are the Net Income projections
for Cooper Companies Inc?

How accurate were the past Net Income estimates
for Cooper Companies Inc?

What are the EPS projections
for Cooper Companies Inc?

How accurate were the past EPS estimates
for Cooper Companies Inc?

What are the EBIT projections
for Cooper Companies Inc?

How accurate were the past EBIT estimates
for Cooper Companies Inc?

Compare the revenue forecasts
for Cooper Companies Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cooper Companies Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cooper Companies Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cooper Companies Inc compared to its peers.

Compare the P/E ratios
of Cooper Companies Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cooper Companies Inc with its peers.

Analyze the financial leverage
of Cooper Companies Inc compared to its main competitors.

Show all profitability ratios
for Cooper Companies Inc.

Provide ROE
for Cooper Companies Inc.

Provide ROA
for Cooper Companies Inc.

Provide ROIC
for Cooper Companies Inc.

Provide ROCE
for Cooper Companies Inc.

Provide Gross Margin
for Cooper Companies Inc.

Provide Operating Margin
for Cooper Companies Inc.

Provide Net Margin
for Cooper Companies Inc.

Provide FCF Margin
for Cooper Companies Inc.

Show all solvency ratios
for Cooper Companies Inc.

Provide D/E Ratio
for Cooper Companies Inc.

Provide D/A Ratio
for Cooper Companies Inc.

Provide Interest Coverage Ratio
for Cooper Companies Inc.

Provide Altman Z-Score Ratio
for Cooper Companies Inc.

Provide Quick Ratio
for Cooper Companies Inc.

Provide Current Ratio
for Cooper Companies Inc.

Provide Cash Ratio
for Cooper Companies Inc.

What is the historical Revenue growth
over the last 5 years for Cooper Companies Inc?

What is the historical Net Income growth
over the last 5 years for Cooper Companies Inc?

What is the current Free Cash Flow
of Cooper Companies Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cooper Companies Inc.

Business Breakdown

Cooper Companies Inc. is a dynamic leader in the global medical device industry, primarily recognized for its innovative contact lens solutions and surgical products. Founded in 1958 and headquartered in Pleasonton, California, Cooper is dedicated to improving the quality of life for patients with vision-related issues. The company's operations are divided into two key segments: CooperVision, which produces a wide range of specialty and daily disposable contact lenses, and CooperSurgical, which focuses on women's health products. With a strong commitment to research and development, Cooper continuously invests in cutting-edge technologies, poised to capitalize on the growing demand for visio...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cooper Companies Inc

Current Assets 1.9B
Cash & Short-Term Investments 109.7m
Receivables 739m
Other Current Assets 1.1B
Non-Current Assets 10.2B
PP&E 1.7B
Intangibles 5.6B
Other Non-Current Assets 2.9B
Current Liabilities 969.5m
Accounts Payable 222m
Accrued Liabilities 156.5m
Short-Term Debt 39.8m
Other Current Liabilities 551.2m
Non-Current Liabilities 3.2B
Long-Term Debt 2.6B
Other Non-Current Liabilities 621.9m
Efficiency

Earnings Waterfall
Cooper Companies Inc

Revenue
3.8B USD
Cost of Revenue
-1.3B USD
Gross Profit
2.5B USD
Operating Expenses
-1.9B USD
Operating Income
643m USD
Other Expenses
-283.7m USD
Net Income
359.3m USD

Free Cash Flow Analysis
Cooper Companies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Cooper celebrated its first billion-dollar revenue quarter, driven by strong performances from CooperVision and CooperSurgical. The company reported non-GAAP earnings per share of $0.96, reflecting a 14% year-over-year increase. CooperVision achieved record quarterly revenues of $676 million, growing 10%, while CooperSurgical posted $327 million in revenue, up 5%. The firm's guidance for fiscal 2024 foresees consolidated revenues of $3.89-$3.91 billion, with non-GAAP EPS expected to reach $3.64-$3.67. Notable recent acquisitions include ZyMot and obp Surgical, aimed at strengthening their market position.

What is Earnings Call?
Fundamental Scores

0I3I Profitability Score
Profitability Due Diligence

Cooper Companies Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Net Income
Positive 3-Years Revenue Growth
55/100
Profitability
Score

Cooper Companies Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

0I3I Solvency Score
Solvency Due Diligence

Cooper Companies Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

Cooper Companies Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0I3I Price Targets Summary
Cooper Companies Inc

Wall Street analysts forecast 0I3I stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0I3I is 116.4 USD with a low forecast of 93.19 USD and a high forecast of 136.71 USD.

Lowest
Price Target
93.19 USD
11% Downside
Average
Price Target
116.4 USD
12% Upside
Highest
Price Target
136.71 USD
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 0I3I?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for COO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Cooper Companies Inc

Country

United States of America

Industry

Health Care

Market Cap

21.4B MXN

Dividend Yield

0%

Description

The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 12,000 full-time employees. The firm operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Contact

CALIFORNIA
San Ramon
6101 Bollinger Canyon Rd Ste 500
+19254603600.0
www.coopercos.com

IPO

1983-01-21

Employees

12 000

Officers

President, CEO & Non-Independent Director
Mr. Albert G. White III
Executive VP, CFO & Treasurer
Mr. Brian G. Andrews
Executive VP & COO
Mr. Daniel G. McBride Esq.
President of CooperSurgical, Inc.
Ms. Holly R. Sheffield
President of CooperVision, Inc.
Mr. Gerard H. Warner III
Senior VP & Chief Accounting Officer
Mr. Agostino Ricupati
Show More
Vice President of Investor Relations & Risk Management
Mr. Kim Duncan
General Counsel & Corporate Secretary
Mr. Nicholas S. Khadder
Show Less

See Also

Discover More
What is the Intrinsic Value of one 0I3I stock?

The intrinsic value of one 0I3I stock under the Base Case scenario is 0.77 USD.

Is 0I3I stock undervalued or overvalued?

Compared to the current market price of 104.23 USD, Cooper Companies Inc is Overvalued by 99%.

Back to Top